←Back to Expert Scholars
Translational Medicine / 转化医学Ki67 & Proliferation
Nadia Harbeck
MD, PhD
🏢LMU University Hospital Munich🌐Germany
Head, Breast Center
80
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Nadia Harbeck co-chairs European consensus panels on Ki67 use in breast cancer treatment decisions. She leads the ADAPT trial program evaluating short-term endocrine response including Ki67 dynamics. Her work helped establish proliferation biomarkers in routine German clinical practice.
Share:
🧪Research Fields 研究领域
Breast cancer biomarkers
Ki67 European panel
ADAPT trials
Early breast cancer
Translational research
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Nadia Harbeck 的研究动态
Follow Nadia Harbeck's research updates
留下邮箱，当我们发布与 Nadia Harbeck（LMU University Hospital Munich）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment